Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126098521 | 12609852 | 1 | I | 201605 | 20160706 | 20160801 | 20160801 | PER | US-TEVA-675257ACC | TEVA | 39.87 | YR | F | Y | 136.20000 | KG | 20160801 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126098521 | 12609852 | 1 | PS | PLAN B ONE-STEP | LEVONORGESTREL | 1 | 21998 | 1.5 | MG | TABLET | |||||||||
| 126098521 | 12609852 | 2 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126098521 | 12609852 | 3 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 126098521 | 12609852 | 4 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126098521 | 12609852 | 1 | Post coital contraception |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126098521 | 12609852 | Menstruation delayed | |
| 126098521 | 12609852 | Menstruation irregular | |
| 126098521 | 12609852 | Premenstrual syndrome | |
| 126098521 | 12609852 | Vulvovaginal dryness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126098521 | 12609852 | 1 | 20160503 | 20160503 | 0 |